BUL/SFT (BUL/SFT)

Bulgarian Stock Exchange: BUL/SFT · EUR

€3.80

+0.34 (+9.8%)· Recorded snapshot

Market cap	130.2M
Revenue (ttm)	1.3B
Net income (ttm)	24.1M
EPS (ttm)	€0.71
Shares out	34.3M
P/E (trailing)	5.4x
Volume	15,801
Beta	0.17

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.3B
Net income (ttm): 24.1M
EPS (ttm): €0.71
P/E (trailing): 5.4x
Market cap: 130.2M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E5.4

P25 n/aP50 n/aP75 n/a

ROE20.6

P25 n/aP50 n/aP75 n/a

ROIC9.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BUL/SFT indicators

Market & fundamental data

Available fields

229

Groups with data

Currency

EUR

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Bulgaria
Country code	BG
Earnings date	2026-11-26
Employees	3,750
Employees change	-12
Employees growth	-0.32%
Enterprise value	EUR 309.7M
Exchange	Bulgarian Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2006
Industry	Pharmaceutical Preparations
Is primary listing	Yes
ISIN number	BG1100086070
Last earnings date	2026-03-04
Last refreshed	2026-10-28
Market cap	EUR 130.2M
Next earnings date	2026-11-26
Price	EUR 3.80
Price currency	EUR
SIC code	2834
Stock price date	2026-10-28
Symbol	bul/SFT
Website	https://www.sopharmatrading.bg

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	16.28x
Average P/E ratio (3Y)	6.14x
Average P/E ratio (5Y)	9.87x
Earnings yield	18.58%
EV/Earnings	12.37x
EV/EBIT	8.2x
EV/EBITDA	5.24x
EV/FCF	12.68x
EV/Sales	0.24x
FCF / EV yield	7.89%
FCF yield	19.82%
Graham number	7.70209
Graham upside	122.6%
Lynch fair value	EUR 17.65
Lynch upside	410.03%
P/B ratio	0.92x
P/E ratio	5.38x
P/FCF ratio	5.04x
P/OCF ratio	3.69x
P/S ratio	0.09x
Price / tangible book value	1.19x
Price/EBITDA ratio	3.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	2.9%
EBITDA margin	3.13%
Effective tax rate	18.21%
FCF margin	1.88%
Gross margin	13.23%
Operating margin	2.9%
Pretax margin	2.36%
Profit margin	1.92%
Profit per employee	EUR 6,425
Revenue per employee	EUR 333,936
ROA	4.75%
ROA (5Y)	4.31%
ROCE	18.73%
ROE	20.64%
ROE (5Y)	20.98%
ROIC	9.93%
ROIC (5Y)	9.96%
Tax / revenue	0.43%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-18.92%
EPS growth (Q)	-29.92%
EPS growth (QoQ)	-21.35%
EPS growth 10Y	15.5%
EPS growth 3Y	54.84%
EPS growth 5Y	30.89%
FCF growth 3Y	18.81%
Gross profit growth	9.55%
Gross profit growth (Q)	0.17%
Gross profit growth 3Y	20.41%
Gross profit growth 5Y	20.41%
Net income growth	-18.78%
Net income growth (Q)	-28.73%
Net income growth (QoQ)	-21.14%
Net income growth 3Y	54.8%
Net income growth 5Y	30.78%
OCF growth	1,072.91%
OCF growth 3Y	21.13%
Operating income growth	-10.34%
Operating income growth (Q)	-26.99%
Operating income growth 3Y	15.55%
Operating income growth 5Y	30.91%
Revenue growth	13.12%
Revenue growth (Q)	9.92%
Revenue growth (QoQ)	4.58%
Revenue growth 10Y	15.06%
Revenue growth 3Y	15.57%
Revenue growth 5Y	14.06%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -8.6M
Depreciation and amortization	EUR 2.8M
EBIT	EUR 36.4M
EBITDA	EUR 39.2M
EPS	EUR 0.71
FCF per share	EUR 0.69
Financing cash flow	EUR -18.7M
Free cash flow	EUR 23.5M
Gross profit	EUR 165.7M
Income taxes	EUR 5.4M
Investing cash flow	EUR -13.3M
Net borrowing	EUR -20.1M
Net cash flow	EUR 149,392
Net income	EUR 24.1M
Operating income	EUR 36.4M
Revenue	EUR 1.3B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.44
Book value per share	EUR 3.74
Debt / EBITDA	3.2
Debt / equity	1.41
Debt / FCF	7.75
Goodwill	EUR 2.4M
Interest coverage	5.39
Long-term assets	EUR 113.7M
Long-term liabilities	EUR 64.5M
Net cash (debt)	EUR -177.8M
Net cash / market cap	-149.96%
Net debt / EBITDA	4.54
Net debt / equity	1.37
Net debt / FCF	7.56
Piotroski F-Score	6
Property, plant and equipment	EUR 82.4M
Shareholders' equity	EUR 129.6M
Tangible book value	EUR 99.9M
Tangible book value per share	EUR 2.91
Total assets	EUR 494.3M
Total cash	EUR 4.4M
Total debt	EUR 182.2M
Total liabilities	EUR 364.7M
WACC	3.89%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	2.62
Current assets	EUR 380.6M
Current liabilities	EUR 300.2M
Current ratio	1.27
Inventory turnover	6.35
Net working capital	EUR 199.3M
Quick ratio	0.65
Working capital	EUR 80.4M
Working capital turnover	16.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.17%
Dividend growth (10Y)	11.66%
Dividend growth (3Y)	0.02%
Dividend growth (5Y)	2.05%
Dividend per share	EUR 0.00
Last dividend	EUR 0.30
Payout ratio	0.01%
Shareholder yield	-0.17%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-41.69%
10Y return CAGR	-3.59%
10Y total return	-30.65%
150-day SMA	EUR 3.09
15Y price change	102.35%
15Y return CAGR	8.37%
15Y total return	234.04%
1D price change	9.83%
1M price change	10.97%
1M total return	10.97%
1W price change	1.78%
1W total return	1.78%
1Y price change	-38.57%
1Y return CAGR	-38.59%
1Y total return	-38.57%
20-day SMA	EUR 3.24
200-day SMA	EUR 3.42
3M price change	21.99%
3M total return	21.99%
3Y price change	-43.14%
3Y return CAGR	-17.15%
3Y total return	-43.14%
50-day SMA	EUR 3.11
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 5.85
52-week high date	2025-12-05
52-week low	EUR 2.82
52-week low date	2026-07-23
5Y price change	-28.33%
5Y return CAGR	-6.45%
5Y total return	-28.33%
6M price change	15.44%
6M total return	15.44%
All-time high	EUR 9.05
All-time high date	2017-04-28
All-time low	EUR 0.77
All-time low date	2010-07-26
Average true range (ATR)	EUR 0.07
Average volume	5.6K
Beta (1Y)	0.35
Beta (2Y)	0.22
Beta (5Y)	0.17
Change from 52-week high	-35.04%
Change from 52-week low	34.75%
Change from all-time high	-61.99%
Change from all-time low	346.7%
Change from open	9.2%
Day's gap	0.58%
Dollar volume	EUR 60,044
High price	EUR 3.88
Low price	EUR 3.48
Monthly RSI	32.91
Open price	EUR 3.48
Position in 52-week range	80%
Previous close	EUR 3.46
Price vs 150-day SMA	11.36%
Price vs 20-day SMA	6.07%
Price vs 200-day SMA	0.58%
Price vs 50-day SMA	10.61%
Relative volume	2.82
RSI	70.12
Sharpe ratio	-0.52
Sharpe ratio (3Y)	-0.25
Sharpe ratio (5Y)	-0.18
Sortino ratio	-0.51
Sortino ratio (3Y)	-0.17
Sortino ratio (5Y)	-0.07
Volume	15.8K
Weekly RSI	56.84
YTD price change	-40.69%
YTD total return	-40.69%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4.3M
Shares change (QoQ)	0.26%
Shares change (YoY)	0.17%
Shares held by insiders	0%
Shares held by institutions	1.26%
Shares outstanding	34.3M

Deeper analysis on BUL/SFT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BUL/SFT report

Is a complete BUL/SFT research report available?

No complete published report is available for bul/SFT (BUL/SFT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BUL/SFT (BUL/SFT)

Price

Financial snapshot

Fair-value bridge

Latest news · BUL/SFT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BUL/SFT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BUL/SFT

Frequently asked questions